1. Pink Sheet
  2. >>Rare Diseases

US FDA Seeking New Orphan Products Office Director Amid Internal Moves

 
• By Derrick Gingery

OOPD’s deputy director has been named the acting head of the office responsible for orphan and rare pediatric disease designations.

The FDA says it wants to name a new permanent director of OOPD in the near term. • Source: Alamy

The US Food and Drug Administration continues to search for a permanent director for its Office of Orphan Products Development following the previous director’s transfer to another position at the agency.

Capt

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Rare Diseases

More from Pink Sheet

EU Shaping Biotech Act To Unleash SME Potential

 
• By Neena Brizmohun

European companies, in particular small and midsize enterprises, spin-offs and start-ups have a hard time expanding within the single market “because of a complex regulatory framework that is perceived as slow and burdensome,” according to the European Commission.

New EU Filings

 
• By Neena Brizmohun

Brensocatib, Insmed's investigational treatment for non-cystic fibrosis bronchiectasis, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

‘Tectonic’ Arkansas PBM Legislation May Upend Industry

 
• By Tim Casey

Industry will fight hard to prevent other states or the federal government from adopting measures similar to Arkansas' law preventing PBMs from owning pharmacies.